Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding Protein-II modulates RA mediated tumor cell proliferation and invasion

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 217-224

  Vo, Hang P ^a   Crowe, David L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cellular retinoic acid binding protein; Invasion; Matrix metalloproteinase; Proliferation; Retinoic acid receptor; Transcription

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; ENZYME INHIBITION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; TUMOR CELL;

CELL DIVISION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; RECEPTORS, RETINOIC ACID; RNA, ANTISENSE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031900057     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. DeLuca LM: Re noids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 5: 2924-2933, 1993.
2. Lippman SM, Benner SE, and Hong WK: Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res 54: 2025s-2028s, 1994.
3. Moon RC, Mehta RG, and Rao KVN: Retinoids and cancer in experimental animals. In: The Retinoids (second edition) (Sporn MB, Roberts AB, and Goodman DS, eds.) New York, Raven Press, 1994, pp. 573-596.
4. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toht BB, Kramer A, Dimery IW, Skipper P, -and Strong S: 13-cis-retinoic acid in the treatment of oral leukoplakia. N Eng J Med 315: 1501-1505,1986.
5. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, and Goepfert H: Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Eng J Med 323: 795-801, 1990.
6. Mangelsdorf DJ, Umesono K, and Evans RM: The retinoid receptors. Jn: The Retinoids (second edition) (Sporn MB, Roberts AB, and Goodman DS, eds). New York, Raven Press, 1994, pp. 319-350.
7. Leid M, Kastner P, and Chambon P: Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Bioch sci 17: 427-433, 1992.
8. Sani B and Hill D: Retinoic acid: a binding protein in chick embryo metatarsal skin. Biochem Biophys Res Commun 61: 1276-1281, 1974.
9. Bailey J and Siu CH: Purification and characterization of a murine cellular retinoic acid binding protein. Biochem Cell Biol 66: 750-757, 1987.
10. scigenthaler G, Samson J, Bernard JP, Fiore-Donno G, and Saurat JH: Retinoid binding proteins in human oral mucosa. J Oral Pathol 17: 106-112, 1988.
11. Bailey J and Siu CH: Purification and characterization of a novel binding protein for retinoic acid from neonatal rat. J Biol Chem 263: 9326-9332, 1988.
12. Zhang J, Liu ZP, Jones TA, Gierasch LM, and Sambrook JF: Mutating the charged residues in the binding pocket of cellular retinoic acid binding protein simultaneously reduces its binding affinity to retinoic acid and increases its thermostability. Proteins 13: 87-99, 1992.
13. Eller MS, Oleksiak MF, McQuaid TJ, McAfee SG, and Gilchrest BA: The molecular cloning and expression of two CRABP cDNAs from human skin. Exp Cell Res 199: 328-336, 1992.
14. Astrom A, Pettersson U, and Voorhees JJ: Structure of the human cellular retinoic acid binding protein II gene. J Biol Chem 267: 25251-25255, 1992.
15. Takase S, Ong D, and Chytil F: Transfer of retinoic acid from its complex with cellular retinoic acid binding protein to the nucleus. Arch Biochem Biophys 247: 328-334, 1986.
16. Barkai U and Sherman M: Analyses of the interactions between retinoid binding proteins and embryonal carcinoma cells. J Cell Biol 104: 671-678, 1987.
17. Maden M, Ong D, Summerbell D, and Chytil F: Spatial distribution of cellular protein binding to retinoic acid in the chick limb bud. Nature 335: 733-735, 1988.
18. Boylan JF and Gudas LJ: The level of CRABP I expression influences the amounts and types of all trans retinoic acid metabolites in F9 teratocarcinoma stem cells. J Biol Chem 267: 21486-21491, 1992.
19. Posch KC, Burns RD, and Napoli JL: Biosynthesis of all trans retinoic acid from retinal. J Biol Chem 267: 19676-19682, 1992.
20. Boylan JF and Gudas LJ: Overexpression of the cellular retinoic acid binding protein I (CRABP 1) results in a reduction in differentiation specific gene expression in F9 teratocarcinoma cells. J Cell Biol 112: 965-979, 1991.
21. Hu L, Crowe DL, Rheinwald JG, Chambon P, and Gudas LJ: Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res 51: 3972-3981, 1991.
22. Astrom A, Tavakkol A, Pettersson U, Cromie M, Elder JT, and Voorhees JJ: Molecular cloning of two human cellular retinoic acid binding proteins (CRABP). J Biol Chem 266: 17662-17666, 1991.
23. Durand B, Saunders M, Leroy P, Leid M, and Chambon P: All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell 71: 73-85, 1992.
24. Jiang CK, Connoily D, and Blumenberg M: Comparison of methods for transfection of human epidermal keratinocytes. J Invest Derm 97: 969-973, 1991.
25. Crowe DL: Retinoic acid mediates posttranscriptional regulation of keratin 19 mRNA levels. J Cell sci 106: 183-188, 1993.
26. Tyner AL, Eichman MJ, and Fuchs E: The sequence of a type II keratin gene expressed in human skin: conservation of structure among all intermediate filament genes. Proc Natl Acad sci USA 82: 4683-4687, 1985.
27. Kulesh DA, Cecena G, Darmon YM, Vasseur M, amd Oshima RG: Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol Cell Biol 9: 1553-1565, 1989.
28. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, and Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993.
29. Siegenthaler G, Saurai JH, and Ponec M: Terminal differentiation in cultured human keratinocytes is associated with increased levels of cellular retinoic acid binding protein. Exp Cell Res 178: 114-126, 1988.
30. Hudson LG, Santon JB, Glass CK, and Gill GN: Ligand activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell 62: 1165-1175, 1990.
31. Navarro JM, Casatorres J, and Jorcano JL: Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. J Biol Chem 270: 21362-21367, 1995.
32. Helige C, Smolle J, Zellnig G, Hartmann E, Fink-Puches R, Kerl H, and Tritthart HA: Inhibition of K1735-M2 melanoma cell invasion in vitro by retinoic acid. Clin Exp Metastasis 11: 409-418, 1993.
33. Hendrix MJC, Wood WR, and Seftor EA: Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its. relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 50: 4121-4130, 1990.
34. II28 promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J 15: 3093-3104, 1996.
35. Mclnerney EM, Tsai MJ, O'Malley BW, and Katzenellenbogen BS: Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad sci USA 93: 10069-10073, 1996.
36. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, and Evans RM: Role of CBP/p300 in nuclear receptor signaling. Nature 383: 99-103, 1996.
37. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, and Rosenfeld MG: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414, 1996.
38. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, and Glass CK: Polarity specific activities of retinoic acid receptors determined by a co-repressor. Nature 377: 451-454, 1995.
39. Chen JD, Umesono K, and Evans RM: SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad sci USA 93: 7567-7571, 1996.
40. Casanova J, Helmer E, Selmi-Ruby S, Qi JS, Au Fliegner M, Desai-Yajnik V, Koudinova N, Yarm F, Raaka BM, and Samuels HH: Functional evidence for ligand dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol Cell Biol 14: 5756-5765, 1994.
41. Busch C, Siegenthaler G, Vahlquist A, Nordlinder H, Sundelin J, Saksena P, and Eriksson U: Expression of cellular retinoid-binding proteins during normal and abnormal epidermal differentiation. J Invest Derm 99: 795-802, 1992.
42. Eller MS, Harkness DD, Bhawan J, and Gilchrest BA: Epidermal differentiation enhances CRABP II expression in human skin. J Invest Derm 103: 785-790, 1994.
43. Rheinwald JG and Beckett MA: Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22: 629-632, 1981.
44. Ermich T, Schulz J, and Schumann D: Pattern of oral cytokeratins. I. SDS-electrophoretic analysis of the frequency of cytoskeletal keratins in the normal human mucosa of mouth. Biomed Biochim Acta 47: 737-742, 1988.
45. Ermich T, Schulz J, Raabe G, and Schumann D: Pattern of oral cytokeratins. III. SDS-electrophoretic analysis and immunoblotting of cytokeratins in leukoplakias and squamous cell carcinomas of the oral mucosa. Biomed Biochim Acta 48: 393-401, 1989.
46. Fuchs E and Green H: Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 25: 617-625, 1981.